Gastroenterology · Malabsorption Syndromes
The facts most likely to be tested
Short bowel syndrome is defined as a state of malabsorption resulting from extensive surgical resection, congenital defects, or disease-associated loss of functional small intestine.
Resection of the terminal ileum specifically leads to bile acid malabsorption, resulting in steatorrhea and the inability to absorb vitamin B12.
Patients with terminal ileal resection are at high risk for calcium oxalate nephrolithiasis because unabsorbed fatty acids bind calcium, leaving oxalate free to be absorbed by the colon.
Gastric hypersecretion occurs in the immediate postoperative period due to the loss of inhibitory hormones like GLP-1 and PYY, necessitating proton pump inhibitor therapy.
Small intestinal bacterial overgrowth (SIBO) is a common complication due to stasis and loss of the ileocecal valve, which normally prevents colonic bacteria from refluxing into the small bowel.
Intestinal adaptation is the physiological process where the remaining bowel undergoes hyperplasia and villus hypertrophy to increase the absorptive surface area.
First-line management for short bowel syndrome involves enteral nutrition to stimulate mucosal adaptation, supplemented by parenteral nutrition if caloric requirements cannot be met.
Vignette unlocked
A 45-year-old male presents to the clinic with a 3-month history of chronic, foul-smelling diarrhea and weight loss. His medical history is significant for a Crohn's disease flare requiring a terminal ileal resection one year ago. Laboratory studies reveal a macrocytic anemia and elevated urinary oxalate levels. He reports frequent episodes of flank pain consistent with nephrolithiasis.
What is the most likely mechanism for this patient's increased risk of kidney stones?
Increased colonic absorption of dietary oxalate due to calcium saponification by unabsorbed fatty acids.
This question tests the pathophysiology of oxalate stone formation in short bowel syndrome (Bet 3), where unabsorbed fatty acids bind calcium, preventing the formation of insoluble calcium-oxalate in the gut and increasing systemic oxalate absorption.
Full handout
High yield triage
Etiology / Epidemiology
Occurs after massive small bowel resection due to Crohn's disease, mesenteric ischemia, or volvulus.
Clinical Manifestations
Presents with malabsorptive diarrhea, steatorrhea, and profound electrolyte depletion.
Diagnosis
Diagnosis is clinical; <200 cm of residual small bowel is the critical threshold for functional impairment.
Treatment
Management requires parenteral nutrition initially, transitioning to enteral nutrition to promote intestinal adaptation.
Prognosis
High risk of D-lactic acidosis and nephrolithiasis; requires lifelong monitoring of micronutrients.
Full handout
Epidemiology & Etiology
Most common in adults following surgical resection for Crohn's disease or acute mesenteric ischemia. In neonates, necrotizing enterocolitis is the primary driver. The severity is directly proportional to the length and site of the resected segment.
Pertinent Anatomy
Resection of the terminal ileum is most critical, as it is the exclusive site for bile acid and vitamin B12 absorption. Loss of the ileocecal valve increases the risk of small intestinal bacterial overgrowth (SIBO).
Pathophysiology
Reduced surface area leads to malabsorption of macronutrients, electrolytes, and water. Rapid transit time prevents adequate nutrient contact with the mucosa. The colon may compensate by fermenting unabsorbed carbohydrates into short-chain fatty acids, but this can lead to metabolic acidosis.
Clinical Manifestations
Patients present with chronic watery diarrhea and steatorrhea. Physical exam reveals signs of dehydration and malnutrition. Red flag symptoms include severe electrolyte imbalances and weight loss. Watch for D-lactic acidosis, which presents with altered mental status.
Diagnosis
Diagnosis is based on the clinical history of extensive bowel resection. The gold standard for assessing functional capacity is measuring the length of the remaining small bowel. A residual length of <200 cm is generally required to meet the definition of clinical syndrome.
Treatment
Initial management focuses on parenteral nutrition to stabilize fluid and electrolyte status. Enteral nutrition is introduced early to stimulate intestinal adaptation. Avoid high-fat diets to prevent worsening steatorrhea. Use loperamide to slow transit time.
Prognosis
Patients are at high risk for nephrolithiasis due to increased oxalate absorption. Long-term complications include micronutrient deficiencies and liver disease associated with parenteral nutrition. Intestinal transplantation is reserved for patients with irreversible intestinal failure.
Differential Diagnosis
Celiac disease: positive serology and biopsy
Chronic pancreatitis: low fecal elastase
SIBO: positive hydrogen breath test
Carcinoid syndrome: elevated 5-HIAA
VIPoma: elevated vasoactive intestinal peptide